About NYC CLL
The NYC CLL Consortium Meeting is a premier annual educational forum dedicated to advancing the management of chronic lymphocytic leukemia (CLL). Led by investigators from the NYC CLL Consortium, the inaugural program brings together academic and community hematologists/oncologists, fellows, advanced practice providers, and multidisciplinary clinicians involved in CLL research and care.
Meeting Highlights
• Latest biologic discoveries, translational insights, and pivotal clinical trial data
• Collaboration among leading CLL experts and institutions
• Practical strategies for integrating emerging therapies into real-world practice
• Discussion and expert interpretation of the latest data presented at ASH
Why Attend
CLL management is evolving rapidly - with the rise of combination treatment strategies, an expanding interplay between clinical trial findings and community practice, an aging patient population, and the emergence of novel therapeutics. This meeting is designed to help clinicians stay ahead of these changes.
Join leading experts as they translate the latest science into actionable clinical insights. Attendees will gain practical tools and confidence to implement evolving treatment approaches and optimize patient outcomes across both academic and community care settings.
Adam S. Kittai, MD
Chairman
Richard R. Furman, MD
Co-Chairperson
Nicole Lamanna, MD
Co-Chairperson
Andrew D. Zelenetz, MD, PhD
Co-Chairperson
WHEN
WHERE
ORGANIZER
Friday, February 5, 2027
7:30AM - 6:10PM
CUNY Graduate Center
365 5th Avenue | New York, NY
Melton Medical Education, LLC
(512) 619-5534
info@MeltonMedEd.com
